Literature DB >> 11423592

Therapeutic value of octreotide for patients with severe dumping syndrome--a review of randomised controlled trials.

J Li-Ling1, M Irving.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11423592      PMCID： PMC1760970          DOI： 10.1136/pmj.77.909.441

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  12 in total

1.  Systematic reviews and meta-analyses: the value for surgery.

Authors:  T A Sheldon
Journal:  Br J Surg       Date:  1999-08       Impact factor: 6.939

Review 2.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

3.  Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.

Authors:  W O Richards; R Geer; T M O'Dorisio; T Robarts; K L Parish; D Rice; G Woltering; N N Abumrad
Journal:  J Surg Res       Date:  1990-12       Impact factor: 2.192

Review 4.  The place of octreotide in the medical management of the dumping syndrome.

Authors:  C Scarpignato
Journal:  Digestion       Date:  1996       Impact factor: 3.216

Review 5.  The dumping syndrome. Current insights into pathophysiology, diagnosis and treatment.

Authors:  J Vecht; A A Masclee; C B Lamers
Journal:  Scand J Gastroenterol Suppl       Date:  1997

6.  Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy.

Authors:  J N Primrose; D Johnston
Journal:  Br J Surg       Date:  1989-02       Impact factor: 6.939

7.  Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.

Authors:  W P Hopman; R G Wolberink; C B Lamers; J H Van Tongeren
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

8.  Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome.

Authors:  W L Hasler; H C Soudah; C Owyang
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

9.  Control of dumping symptoms by somatostatin analogue in patients after gastric surgery.

Authors:  J L Gray; H T Debas; S J Mulvihill
Journal:  Arch Surg       Date:  1991-10

10.  Long acting somatostatin analogue in dumping syndrome.

Authors:  Z Tulassay; T Tulassay; R Gupta; G Cierny
Journal:  Br J Surg       Date:  1989-12       Impact factor: 6.939
View more
  6 in total

Review 1.  Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment.

Authors:  Patrick Berg; Richard McCallum
Journal:  Dig Dis Sci       Date:  2015-09-22       Impact factor: 3.199

2.  The Role of the Nutritionist in a Multidisciplinary Bariatric Surgery Team.

Authors:  Luigi Schiavo; Vincenzo Pilone; Gianluca Rossetti; Antonio Iannelli
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

Review 3.  Gastrointestinal complications of fundoplication.

Authors:  Frances Connor
Journal:  Curr Gastroenterol Rep       Date:  2005-06

4.  Alpha2-adrenergic receptors attenuate secretagogue-induced endocytosis and promote exocytosis of intestinal NHE2 and NHE3.

Authors:  Mark W Musch; Donna L Arvans; Hervé Paris; Eugene B Chang
Journal:  J Pharmacol Exp Ther       Date:  2009-06-25       Impact factor: 4.030

5.  Dumping Syndrome.

Authors:  William L. Hasler
Journal:  Curr Treat Options Gastroenterol       Date:  2002-04

6.  Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients.

Authors:  Flavio A Cadegiani; Osvalmir Sá Silva
Journal:  Diabetes Metab Syndr Obes       Date:  2016-12-07       Impact factor: 3.168
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.